{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:28:23Z","timestamp":1790886503250,"version":"4.1.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010058","name":"Stiftelsen L\u00e4kare mot AIDS Forskningsfond","doi-asserted-by":"publisher","award":["FOb2020-0019"],"award-info":[{"award-number":["FOb2020-0019"]}],"id":[{"id":"10.13039\/501100010058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010058","name":"Stiftelsen L\u00e4kare mot AIDS Forskningsfond","doi-asserted-by":"publisher","award":["FOa2021-0009"],"award-info":[{"award-number":["FOa2021-0009"]}],"id":[{"id":"10.13039\/501100010058","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["HORIZON-HLTH-2021-CORONA-01, 101046016"],"award-info":[{"award-number":["HORIZON-HLTH-2021-CORONA-01, 101046016"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-01675"],"award-info":[{"award-number":["2016-01675"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","award":["20190451"],"award-info":[{"award-number":["20190451"]}],"id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although mRNA SARS-CoV-2 vaccines are generally safe and effective, in certain immunocompromised individuals they can elicit poor immunogenic responses. Among these individuals, people living with HIV (PLWH) have poor immunogenicity to several oral and parenteral vaccines. As the gut microbiome is known to affect vaccine immunogenicity, we investigated whether baseline gut microbiota predicts immune responses to the BNT162b2 mRNA SARS-CoV-2 vaccine in healthy controls and PLWH after two doses of BNT162b2. Individuals with high spike IgG titers and high spike-specific CD4<jats:sup>+<\/jats:sup> T-cell responses against SARS-CoV-2 showed low \u03b1-diversity in the gut. Here, we investigated and presented initial evidence that the gut microbial composition influences the response to BNT162b2 in PLWH. From our predictive models, <jats:italic>Bifidobacterium<\/jats:italic> and <jats:italic>Faecalibacterium<\/jats:italic> appeared to be microbial markers of individuals with higher spike IgG titers, while <jats:italic>Cloacibacillus<\/jats:italic> was associated with low spike IgG titers. We therefore propose that microbiome modulation could optimize immunogenicity of SARS-CoV-2 mRNA vaccines.<\/jats:p>","DOI":"10.1038\/s41522-023-00461-w","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T06:01:58Z","timestamp":1703052118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-7366","authenticated-orcid":false,"given":"Shilpa","family":"Ray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswathy","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vesterbacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-4919","authenticated-orcid":false,"given":"Giorgio","family":"Gabarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gustaf","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Buggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lokeshwaran","family":"Manoharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3793-4064","authenticated-orcid":false,"given":"Margaret S\u00e4llberg","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"S\u00f6nnerborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"461_CR1","unstructured":"World Health Organization (accessed 14 July 2023). https:\/\/covid19.who.int\/."},{"key":"461_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"461_CR3","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","volume":"385","author":"HM El Sahly","year":"2021","unstructured":"El Sahly, H. M. et al. Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. N. Engl. J. Med. 385, 1774\u20131785 (2021).","journal-title":"N. Engl. J. Med."},{"key":"461_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S1473-3099(21)00460-6","volume":"22","author":"M Antonelli","year":"2022","unstructured":"Antonelli, M. et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 22, 43\u201355 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"461_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2021","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"461_CR6","doi-asserted-by":"publisher","first-page":"e2236670","DOI":"10.1001\/jamanetworkopen.2022.36670","volume":"5","author":"S Carazo","year":"2022","unstructured":"Carazo, S. et al. Estimated protection of prior SARS-CoV-2 infection against reinfection with the Omicron variant among messenger RNA\u2013vaccinated and nonvaccinated individuals in Quebec, Canada. JAMA Netw. Open 5, e2236670 (2022).","journal-title":"JAMA Netw. Open"},{"key":"461_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11357-021-00323-3","volume":"43","author":"J Connors","year":"2021","unstructured":"Connors, J., Bell, M. R., Marcy, J., Kutzler, M. & Haddad, E. K. The impact of immuno-aging on SARS-CoV-2 vaccine development. Geroscience 43, 31\u201351 (2021).","journal-title":"Geroscience"},{"key":"461_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ageing\/afaa274","volume":"50","author":"RL Soiza","year":"2021","unstructured":"Soiza, R. L., Scicluna, C. & Thomson, E. C. Efficacy and safety of COVID-19 vaccines in older people. Age Ageing 50, 279\u2013283 (2021).","journal-title":"Age Ageing"},{"key":"461_CR9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1189\/jlb.5MR0617-216R","volume":"103","author":"DJ Lynn","year":"2018","unstructured":"Lynn, D. J. & Pulendran, B. The potential of the microbiota to influence vaccine responses. J. Leukoc. Biol. 103, 225\u2013231 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"461_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imm.12231","volume":"142","author":"AJ McDermott","year":"2014","unstructured":"McDermott, A. J. & Huffnagle, G. B. The microbiome and regulation of mucosal immunity. Immunology 142, 24\u201331 (2014).","journal-title":"Immunology"},{"key":"461_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1080\/17474124.2021.1991311","volume":"15","author":"S Baradaran Ghavami","year":"2021","unstructured":"Baradaran Ghavami, S. et al. Cross-talk between immune system and microbiota in COVID-19. Expert Rev. Gastroenterol. Hepatol. 15, 1281\u20131294 (2021).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"461_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.humic.2018.10.001","volume":"10","author":"S Mezouar","year":"2018","unstructured":"Mezouar, S. et al. Microbiome and the immune system: from a healthy steady-state to allergy associated disruption. Hum. Microbiome J. 10, 11\u201320 (2018).","journal-title":"Hum. Microbiome J."},{"key":"461_CR13","first-page":"864","volume":"7","author":"D Li","year":"2016","unstructured":"Li, D., Breiman, A., Le Pendu, J. & Uyttendaele, M. Anti-viral effect of Bifidobacterium adolescentis against noroviruses. Front. Microbiol. 7, 864 (2016).","journal-title":"Front. Microbiol."},{"key":"461_CR14","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/sj.ejcn.1601093","volume":"54","author":"B-L Chiang","year":"2000","unstructured":"Chiang, B.-L., Sheih, Y., Wang, L., Liao, C. & Gill, H. Enhancing immunity by dietary consumption of a probiotic lactic acid bacterium (Bifidobacterium lactis HN019): optimization and definition of cellular immune responses. Eur. J. Clin. Nutr. 54, 849\u2013855 (2000).","journal-title":"Eur. J. Clin. Nutr."},{"key":"461_CR15","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1093\/ajcn\/74.6.833","volume":"74","author":"HS Gill","year":"2001","unstructured":"Gill, H. S., Rutherfurd, K. J., Cross, M. L. & Gopal, P. K. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am. J. Clin. Nutr. 74, 833\u2013839 (2001).","journal-title":"Am. J. Clin. Nutr."},{"key":"461_CR16","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1126\/science.1198469","volume":"331","author":"K Atarashi","year":"2011","unstructured":"Atarashi, K. et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337\u2013341 (2011).","journal-title":"Science"},{"key":"461_CR17","doi-asserted-by":"publisher","first-page":"e541","DOI":"10.1016\/j.clcc.2018.05.001","volume":"17","author":"J Chen","year":"2018","unstructured":"Chen, J. & Vitetta, L. Inflammation-modulating effect of butyrate in the prevention of colon cancer by dietary fiber. Clin. Colorectal Cancer 17, e541\u2013e544 (2018).","journal-title":"Clin. Colorectal Cancer"},{"key":"461_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature12721","volume":"504","author":"Y Furusawa","year":"2013","unstructured":"Furusawa, Y. et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446\u2013450 (2013).","journal-title":"Nature"},{"key":"461_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41577-021-00554-7","volume":"22","author":"DJ Lynn","year":"2022","unstructured":"Lynn, D. J., Benson, S. C., Lynn, M. A. & Pulendran, B. Modulation of immune responses to vaccination by the microbiota: implications and potential mechanisms. Nat. Rev. Immunol. 22, 33\u201346 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"461_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.3390\/vaccines5040050","volume":"5","author":"L Vitetta","year":"2017","unstructured":"Vitetta, L., Saltzman, E. T., Thomsen, M., Nikov, T. & Hall, S. Adjuvant probiotics and the intestinal microbiome: enhancing vaccines and immunotherapy outcomes. Vaccines 5, 50 (2017).","journal-title":"Vaccines"},{"key":"461_CR21","doi-asserted-by":"publisher","first-page":"e362","DOI":"10.1542\/peds.2013-3937","volume":"134","author":"MN Huda","year":"2014","unstructured":"Huda, M. N. et al. Stool microbiota and vaccine responses of infants. Pediatrics 134, e362\u2013e372 (2014).","journal-title":"Pediatrics"},{"key":"461_CR22","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.chom.2018.07.005","volume":"24","author":"VC Harris","year":"2018","unstructured":"Harris, V. C. et al. Effect of antibiotic-mediated microbiome modulation on rotavirus vaccine immunogenicity: a human, randomized-control proof-of-concept trial. Cell Host Microbe 24, 197\u2013207.e194 (2018).","journal-title":"Cell Host Microbe"},{"key":"461_CR23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiw518","volume":"215","author":"VC Harris","year":"2017","unstructured":"Harris, V. C. et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J. Infect. Dis. 215, 34\u201341 (2017).","journal-title":"J. Infect. Dis."},{"key":"461_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.immuni.2014.09.002","volume":"41","author":"O Pabst","year":"2014","unstructured":"Pabst, O. & Hornef, M. Gut microbiota: a natural adjuvant for vaccination. Immunity 41, 349\u2013351 (2014).","journal-title":"Immunity"},{"key":"461_CR25","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/ni.2067","volume":"12","author":"HI Nakaya","year":"2011","unstructured":"Nakaya, H. I. et al. Systems biology of vaccination for seasonal influenza in humans. Nat. Immunol. 12, 786\u2013795 (2011).","journal-title":"Nat. Immunol."},{"key":"461_CR26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.immuni.2014.08.009","volume":"41","author":"JZ Oh","year":"2014","unstructured":"Oh, J. Z. et al. TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination. Immunity 41, 478\u2013492 (2014).","journal-title":"Immunity"},{"key":"461_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/imm.13105","volume":"158","author":"D Kim","year":"2019","unstructured":"Kim, D. et al. Recognition of the microbiota by Nod2 contributes to the oral adjuvant activity of cholera toxin through the induction of interleukin\u20101\u03b2. Immunology 158, 219\u2013229 (2019).","journal-title":"Immunology"},{"key":"461_CR28","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/nm.4075","volume":"22","author":"D Kim","year":"2016","unstructured":"Kim, D. et al. Nod2-mediated recognition of the microbiota is critical for mucosal adjuvant activity of cholera toxin. Nat. Med. 22, 524\u2013530 (2016).","journal-title":"Nat. Med."},{"key":"461_CR29","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1128\/AEM.02216-08","volume":"75","author":"F Turroni","year":"2009","unstructured":"Turroni, F. et al. Exploring the diversity of the bifidobacterial population in the human intestinal tract. Appl. Environ. Microbiol. 75, 1534\u20131545 (2009).","journal-title":"Appl. Environ. Microbiol."},{"key":"461_CR30","doi-asserted-by":"publisher","first-page":"eabd1525","DOI":"10.1126\/scitranslmed.abd1525","volume":"13","author":"WC Koff","year":"2021","unstructured":"Koff, W. C. et al. Development and deployment of COVID-19 vaccines for those most vulnerable. Sci. Transl. Med. 13, eabd1525 (2021).","journal-title":"Sci. Transl. Med."},{"key":"461_CR31","doi-asserted-by":"publisher","first-page":"100928","DOI":"10.1016\/j.eclinm.2021.100928","volume":"36","author":"R Pellini","year":"2021","unstructured":"Pellini, R. et al. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine. EClinicalMedicine 36, 100928 (2021).","journal-title":"EClinicalMedicine"},{"key":"461_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41574-020-00462-1","volume":"17","author":"N Stefan","year":"2021","unstructured":"Stefan, N., Birkenfeld, A. L. & Schulze, M. B. Global pandemics interconnected\u2014obesity, impaired metabolic health and COVID-19. Nat. Rev. Endocrinol. 17, 135\u2013149 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"461_CR33","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1093\/cid\/ciab381","volume":"73","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller, L. et al. Age-dependent immune response to the Biontech\/Pfizer BNT162b2 coronavirus disease 2019 vaccination. Clin. Infect. Dis. 73, 2065\u20132072 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"461_CR34","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1093\/cid\/ciaa1339","volume":"73","author":"D Dandachi","year":"2021","unstructured":"Dandachi, D. et al. Characteristics, comorbidities, and outcomes in a multicenter registry of patients with human immunodeficiency virus and coronavirus disease 2019. Clin. Infect. Dis. 73, e1964\u2013e1972 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"461_CR35","doi-asserted-by":"publisher","first-page":"e2095","DOI":"10.1093\/cid\/ciaa1605","volume":"73","author":"AM Geretti","year":"2021","unstructured":"Geretti, A. M. et al. Outcomes of coronavirus disease 2019 (COVID-19) related hospitalization among people with human immunodeficiency virus (HIV) in the ISARIC World Health Organization (WHO) clinical characterization protocol (UK): a prospective observational study. Clin. Infect. Dis. 73, e2095\u2013e2106 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"461_CR36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/hiv.13037","volume":"22","author":"C Hoffmann","year":"2021","unstructured":"Hoffmann, C. et al. Immune deficiency is a risk factor for severe COVID\u201019 in people living with HIV. HIV Med. 22, 372\u2013378 (2021).","journal-title":"HIV Med."},{"key":"461_CR37","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.rvsc.2021.01.021","volume":"136","author":"M Chang","year":"2021","unstructured":"Chang, M. et al. Changes of gut microbiota in pregnant sows induced by 5-Aminolevulinic acid. Res. Vet. Sci. 136, 57\u201365 (2021).","journal-title":"Res. Vet. Sci."},{"key":"461_CR38","unstructured":"Mak, J. W. Y. Modulation of gut microbiota to enhance health and immunity (accessed 2 July 2023). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04884776 (2020)."},{"key":"461_CR39","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/jmv.27485","volume":"94","author":"S Falahi","year":"2022","unstructured":"Falahi, S. & Kenarkoohi, A. Host factors and vaccine efficacy: implications for COVID\u201019 vaccines. J. Med. Virol. 94, 1330\u20131335 (2022).","journal-title":"J. Med. Virol."},{"key":"461_CR40","doi-asserted-by":"publisher","first-page":"104850","DOI":"10.1016\/j.jff.2021.104850","volume":"87","author":"J Chen","year":"2021","unstructured":"Chen, J., Vitetta, L., Henson, J. D. & Hall, S. The intestinal microbiota and improving the efficacy of COVID-19 vaccinations. J. Funct. Foods 87, 104850 (2021).","journal-title":"J. Funct. Foods"},{"key":"461_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0194-5","volume":"5","author":"T Zhao","year":"2020","unstructured":"Zhao, T. et al. Influence of gut microbiota on mucosal IgA antibody response to the polio vaccine. npj Vaccines 5, 47 (2020).","journal-title":"npj Vaccines"},{"key":"461_CR42","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1093\/infdis\/jiy568","volume":"219","author":"I Praharaj","year":"2019","unstructured":"Praharaj, I. et al. Influence of nonpolio enteroviruses and the bacterial gut microbiota on oral poliovirus vaccine response: a study from South India. J. Infect. Dis. 219, 1178\u20131186 (2019).","journal-title":"J. Infect. Dis."},{"key":"461_CR43","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1073\/pnas.1019378108","volume":"108","author":"T Ichinohe","year":"2011","unstructured":"Ichinohe, T. et al. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl Acad. Sci. USA. 108, 5354\u20135359 (2011).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"461_CR44","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","volume":"178","author":"T Hagan","year":"2019","unstructured":"Hagan, T. et al. Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans. Cell 178, 1313\u20131328.e1313 (2019).","journal-title":"Cell"},{"key":"461_CR45","doi-asserted-by":"crossref","unstructured":"Wells, J. M. Immunomodulatory mechanisms of lactobacilli. Microbial Cell Factories 1\u201315 (BioMed Central, 2011).","DOI":"10.1186\/1475-2859-10-S1-S17"},{"key":"461_CR46","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1128\/CMR.00008-07","volume":"20","author":"HM Wexler","year":"2007","unstructured":"Wexler, H. M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20, 593\u2013621 (2007).","journal-title":"Clin. Microbiol. Rev."},{"key":"461_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/ecco-jcc\/jjw136","volume":"11","author":"EK Wright","year":"2017","unstructured":"Wright, E. K. et al. Microbial factors associated with postoperative Crohn\u2019s disease recurrence. J. Crohns Colitis 11, 191\u2013203 (2017).","journal-title":"J. Crohns Colitis"},{"key":"461_CR48","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1128\/IAI.01150-12","volume":"81","author":"PM Chilton","year":"2013","unstructured":"Chilton, P. M., Hadel, D. M., To, T. T., Mitchell, T. C. & Darveau, R. P. Adjuvant activity of naturally occurring monophosphoryl lipopolysaccharide preparations from mucosa-associated bacteria. Infect. Immun. 81, 3317\u20133325 (2013).","journal-title":"Infect. Immun."},{"key":"461_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4269\/ajtmh.19-0355","volume":"102","author":"J Fix","year":"2020","unstructured":"Fix, J. et al. Association between gut microbiome composition and rotavirus vaccine response among Nicaraguan infants. Am. J. Tropical Med. Hyg. 102, 213 (2020).","journal-title":"Am. J. Tropical Med. Hyg."},{"key":"461_CR50","doi-asserted-by":"publisher","first-page":"1848158","DOI":"10.1080\/19490976.2020.1848158","volume":"13","author":"H Zafar","year":"2021","unstructured":"Zafar, H. & Saier, M. H. Jr Gut Bacteroides species in health and disease. Gut Microbes 13, 1848158 (2021).","journal-title":"Gut Microbes"},{"key":"461_CR51","doi-asserted-by":"publisher","first-page":"3380","DOI":"10.1128\/JCM.01137-15","volume":"53","author":"M-C Domingo","year":"2015","unstructured":"Domingo, M.-C. et al. Cloacibacillus sp., a potential human pathogen associated with bacteremia in Quebec and New Brunswick. J. Clin. Microbiol. 53, 3380\u20133383 (2015).","journal-title":"J. Clin. Microbiol."},{"key":"461_CR52","doi-asserted-by":"publisher","unstructured":"Dong, T. S. et al. Gut microbiome profiles associated with steatosis severity in metabolic associated fatty liver disease. Hepatoma Res. 7, https:\/\/doi.org\/10.20517\/2394-5079.2021.55 (2021).","DOI":"10.20517\/2394-5079.2021.55"},{"key":"461_CR53","doi-asserted-by":"publisher","first-page":"e00327","DOI":"10.1128\/mSphere.00327-17","volume":"2","author":"G Bian","year":"2017","unstructured":"Bian, G. et al. The gut microbiota of healthy aged Chinese is similar to that of the healthy young. Msphere 2, e00327\u201300317 (2017).","journal-title":"Msphere"},{"key":"461_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-022-01247-6","volume":"10","author":"A Borgognone","year":"2022","unstructured":"Borgognone, A. et al. Gut microbiome signatures linked to HIV-1 reservoir size and viremia control. Microbiome 10, 59 (2022).","journal-title":"Microbiome"},{"key":"461_CR55","doi-asserted-by":"crossref","unstructured":"Huda, M. N. et al. Bifidobacterium abundance in early infancy and vaccine response at 2 years of age. Pediatrics 143, e20181489 (2019).","DOI":"10.1542\/peds.2018-1489"},{"key":"461_CR56","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1136\/gutjnl-2021-326563","volume":"71","author":"SC Ng","year":"2022","unstructured":"Ng, S. C. et al. Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicity and adverse events. Gut 71, 1106\u20131116 (2022).","journal-title":"Gut"},{"key":"461_CR57","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1021\/acsinfecdis.0c00536","volume":"7","author":"S Ray","year":"2020","unstructured":"Ray, S. et al. Altered gut microbiome under antiretroviral therapy: Impact of efavirenz and zidovudine. ACS Infect. Dis. 7, 1104\u20131115 (2020).","journal-title":"ACS Infect. Dis."},{"key":"461_CR58","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/QAD.0000000000000869","volume":"29","author":"P Nowak","year":"2015","unstructured":"Nowak, P. et al. Gut microbiota diversity predicts immune status in HIV-1 infection. Aids 29, 2409\u20132418 (2015).","journal-title":"Aids"},{"key":"461_CR59","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.3168\/jds.2018-16130","volume":"102","author":"T Ma","year":"2019","unstructured":"Ma, T. et al. Altered mucosa-associated microbiota in the ileum and colon of neonatal calves in response to delayed first colostrum feeding. J. Dairy Sci. 102, 7073\u20137086 (2019).","journal-title":"J. Dairy Sci."},{"key":"461_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13721-1","volume":"10","author":"D Vojinovic","year":"2019","unstructured":"Vojinovic, D. et al. Relationship between gut microbiota and circulating metabolites in population-based cohorts. Nat. Commun. 10, 5813 (2019).","journal-title":"Nat. Commun."},{"key":"461_CR61","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/microorganisms10051020","volume":"10","author":"M Gryaznova","year":"2022","unstructured":"Gryaznova, M. et al. Dynamics of changes in the gut microbiota of healthy mice fed with lactic acid bacteria and bifidobacteria. Microorganisms 10, 1020 (2022).","journal-title":"Microorganisms"},{"key":"461_CR62","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.gpb.2021.09.009","volume":"20","author":"Z-Y Wei","year":"2022","unstructured":"Wei, Z.-Y. et al. Characterization of Changes and Driver Microbes in Gut Microbiota During Healthy Aging Using A Captive Monkey Model. Genomics, Proteomics Bioinformatics 20, 350\u2013365 (2022).","journal-title":"Genomics, Proteomics Bioinformatics"},{"key":"461_CR63","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/medicina57030275","volume":"57","author":"N Matsumoto","year":"2021","unstructured":"Matsumoto, N. et al. Relationship between nutrient intake and human gut microbiota in monozygotic twins. Medicina 57, 275 (2021).","journal-title":"Medicina"},{"key":"461_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13568-023-01539-6","volume":"13","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma. AMB Express 13, 1\u201314 (2023).","journal-title":"AMB Express"},{"key":"461_CR65","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.mad.2019.02.001","volume":"179","author":"N Tuikhar","year":"2019","unstructured":"Tuikhar, N. et al. Comparative analysis of the gut microbiota in centenarians and young adults shows a common signature across genotypically non-related populations. Mech. Ageing Dev. 179, 23\u201335 (2019).","journal-title":"Mech. Ageing Dev."},{"key":"461_CR66","doi-asserted-by":"publisher","first-page":"R832","DOI":"10.1016\/j.cub.2016.08.015","volume":"26","author":"F Kong","year":"2016","unstructured":"Kong, F. et al. Gut microbiota signatures of longevity. Curr. Biol. 26, R832\u2013R833 (2016).","journal-title":"Curr. Biol."},{"key":"461_CR67","doi-asserted-by":"publisher","first-page":"9085","DOI":"10.1007\/s00253-015-6888-3","volume":"99","author":"X Yu","year":"2015","unstructured":"Yu, X. et al. Analysis of the intestinal microbial community structure of healthy and long-living elderly residents in Gaotian Village of Liuyang City. Appl. Microbiol. Biotechnol. 99, 9085\u20139095 (2015).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"461_CR68","doi-asserted-by":"publisher","first-page":"e10667","DOI":"10.1371\/journal.pone.0010667","volume":"5","author":"E Biagi","year":"2010","unstructured":"Biagi, E. et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One 5, e10667 (2010).","journal-title":"PLoS One"},{"key":"461_CR69","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.1128\/AEM.71.10.6438-6442.2005","volume":"71","author":"SP van Tongeren","year":"2005","unstructured":"van Tongeren, S. P., Slaets, J. P., Harmsen, H. J. & Welling, G. W. Fecal microbiota composition and frailty. Appl. Environ. Microbiol. 71, 6438\u20136442 (2005).","journal-title":"Appl. Environ. Microbiol."},{"key":"461_CR70","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/j.1574-6968.2002.tb11467.x","volume":"217","author":"SE Pryde","year":"2002","unstructured":"Pryde, S. E., Duncan, S. H., Hold, G. L., Stewart, C. S. & Flint, H. J. The microbiology of butyrate formation in the human colon. FEMS Microbiol. Lett. 217, 133\u2013139 (2002).","journal-title":"FEMS Microbiol. Lett."},{"key":"461_CR71","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/j.1574-6968.2005.00016.x","volume":"254","author":"C Chassard","year":"2006","unstructured":"Chassard, C. & Bernalier\u2010Donadille, A. H2 and acetate transfers during xylan fermentation between a butyrate\u2010producing xylanolytic species and hydrogenotrophic microorganisms from the human gut. FEMS Microbiol. Lett. 254, 116\u2013122 (2006).","journal-title":"FEMS Microbiol. Lett."},{"key":"461_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2180-9-123","volume":"9","author":"D Mariat","year":"2009","unstructured":"Mariat, D. et al. The Firmicutes\/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol. 9, 1\u20136 (2009).","journal-title":"BMC Microbiol."},{"key":"461_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-020-01903-7","volume":"20","author":"A Vaiserman","year":"2020","unstructured":"Vaiserman, A. et al. Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population. BMC Microbiol. 20, 1\u20138 (2020).","journal-title":"BMC Microbiol."},{"key":"461_CR74","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.chom.2016.09.002","volume":"20","author":"CP Neff","year":"2016","unstructured":"Neff, C. P. et al. Diverse intestinal bacteria contain putative zwitterionic capsular polysaccharides with anti-inflammatory properties. Cell Host Microbe 20, 535\u2013547 (2016).","journal-title":"Cell Host Microbe"},{"key":"461_CR75","doi-asserted-by":"publisher","first-page":"e1000233","DOI":"10.1371\/journal.ppat.1000233","volume":"4","author":"AA Ashkar","year":"2008","unstructured":"Ashkar, A. A., Mossman, K. L., Coombes, B. K., Gyles, C. L. & Mackenzie, R. FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling. PLoS Pathog. 4, e1000233 (2008).","journal-title":"PLoS Pathog."},{"key":"461_CR76","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.3390\/vaccines10071122","volume":"10","author":"K-S Cheung","year":"2022","unstructured":"Cheung, K.-S. et al. Association between recent usage of antibiotics and immunogenicity within six months after COVID-19 vaccination. Vaccines 10, 1122 (2022).","journal-title":"Vaccines"},{"key":"461_CR77","doi-asserted-by":"publisher","first-page":"19376","DOI":"10.1073\/pnas.2000047117","volume":"117","author":"SA Scott","year":"2020","unstructured":"Scott, S. A., Fu, J. & Chang, P. V. Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA. 117, 19376\u201319387 (2020).","journal-title":"Proc. Natl Acad. Sci. USA."},{"key":"461_CR78","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41577-019-0252-2","volume":"20","author":"WS Garrett","year":"2020","unstructured":"Garrett, W. S. Immune recognition of microbial metabolites. Nat. Rev. Immunol. 20, 91\u201392 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"461_CR79","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chom.2016.07.001","volume":"20","author":"M Kim","year":"2016","unstructured":"Kim, M., Qie, Y., Park, J. & Kim, C. H. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20, 202\u2013214 (2016).","journal-title":"Cell Host Microbe"},{"key":"461_CR80","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3390\/microorganisms9050941","volume":"9","author":"T Gautier","year":"2021","unstructured":"Gautier, T. et al. Next-generation probiotics and their metabolites in COVID-19. Microorganisms 9, 941 (2021).","journal-title":"Microorganisms"},{"key":"461_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nmicrobiol.2017.57","volume":"2","author":"PW O\u2019Toole","year":"2017","unstructured":"O\u2019Toole, P. W., Marchesi, J. R. & Hill, C. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat. Microbiol. 2, 1\u20136 (2017).","journal-title":"Nat. Microbiol."},{"key":"461_CR82","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.vaccine.2017.08.069","volume":"36","author":"P Zimmermann","year":"2018","unstructured":"Zimmermann, P. & Curtis, N. The influence of probiotics on vaccine responses\u2013a systematic review. Vaccine 36, 207\u2013213 (2018).","journal-title":"Vaccine"},{"key":"461_CR83","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.chom.2020.04.008","volume":"27","author":"B Di Luccia","year":"2020","unstructured":"Di Luccia, B. et al. Combined prebiotic and microbial intervention improves oral cholera vaccination responses in a mouse model of childhood undernutrition. Cell Host Microbe 27, 899\u2013908.e895 (2020).","journal-title":"Cell Host Microbe"},{"key":"461_CR84","doi-asserted-by":"crossref","unstructured":"Bergman, P. et al. Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial. EBioMedicine 74, 103705 (2021).","DOI":"10.1016\/j.ebiom.2021.103705"},{"key":"461_CR85","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/s41591-022-01700-x","volume":"28","author":"Y Gao","year":"2022","unstructured":"Gao, Y. et al. Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant. Nat. Med. 28, 472\u2013476 (2022).","journal-title":"Nat. Med."},{"key":"461_CR86","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1097\/QAD.0000000000003135","volume":"36","author":"X Xu","year":"2022","unstructured":"Xu, X., Vesterbacka, J., Aleman, S. & Nowak, P. High seroconversion rate after vaccination with mRNA BNT162b2 vaccine against SARS-CoV-2 among people with HIV\u2013but HIV viremia matters? AIDS 36, 479\u2013481 (2022).","journal-title":"AIDS"},{"key":"461_CR87","volume-title":"Babraham Bioinformatics","author":"S Andrews","year":"2010","unstructured":"Andrews, S. Babraham Bioinformatics. (Babraham Institute, Cambridge, United Kingdom, 2010)."},{"key":"461_CR88","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"M Martin","year":"2011","unstructured":"Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10\u201312 (2011).","journal-title":"EMBnet. J."},{"key":"461_CR89","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nmeth.3869","volume":"13","author":"BJ Callahan","year":"2016","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581\u2013583 (2016).","journal-title":"Nat. Methods"},{"key":"461_CR90","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"461_CR91","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2012","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic acids Res. 41, D590\u2013D596 (2012).","journal-title":"Nucleic acids Res."},{"key":"461_CR92","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PloS one 8, e61217 (2013).","journal-title":"PloS one"},{"key":"461_CR93","doi-asserted-by":"crossref","unstructured":"Ginestet, C. ggplot2: Elegant Graphics for Data Analysis. Journal of the Royal Statistical Society Series A: Statistics in Society 174, 245\u2013246 (2011).","DOI":"10.1111\/j.1467-985X.2010.00676_9.x"},{"key":"461_CR94","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, 1\u201318 (2011).","journal-title":"Genome Biol."},{"key":"461_CR95","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.7717\/peerj.1029","volume":"3","author":"F Asnicar","year":"2015","unstructured":"Asnicar, F., Weingart, G., Tickle, T. L., Huttenhower, C. & Segata, N. Compact graphical representation of phylogenetic data and metadata with GraPhlAn. PeerJ 3, e1029 (2015).","journal-title":"PeerJ"},{"key":"461_CR96","unstructured":"Revelle, W. & Revelle, M. W. Package \u2018psych\u2019. The Comprehensive R Archive Network 337, 338 (2015)."},{"key":"461_CR97","unstructured":"Revelle, W. psych: Procedures for Psychological, Psychometric, and Personality Research. Northwestern University, Evanston, Illinois. R package version 2.2.3 (2022). Retrieved from https:\/\/CRAN.R-project.org\/package=psych."},{"key":"461_CR98","unstructured":"Wei, T. et al. package \u201ccorrplot\u201d: Visualization of a Correlation Matrix. 2017. Version 0.84 (2021)."},{"key":"461_CR99","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498\u20132504 (2003).","journal-title":"Genome Res."},{"key":"461_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1\u201321 (2014).","journal-title":"Genome Biol."}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-023-00461-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-023-00461-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-023-00461-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T07:07:05Z","timestamp":1703056025000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-023-00461-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1038\/s41522-023-00461-w","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"5 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The ethical permit was reviewed and approved by the Swedish Ethical Review Authority (ID 2021-00451), and all participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"104"}}